MYSEUM INC (MYSE) Fundamental Analysis & Valuation

NASDAQ:MYSE • US23816M2061

Current stock price

1.69 USD
+0.07 (+4.32%)
At close:
1.69 USD
0 (0%)
After Hours:

This MYSE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. MYSE Profitability Analysis

1.1 Basic Checks

  • In the past year MYSE has reported negative net income.
  • MYSE had a negative operating cash flow in the past year.
  • In the past 5 years MYSE always reported negative net income.
  • In the past 5 years MYSE always reported negative operating cash flow.
MYSE Yearly Net Income VS EBIT VS OCF VS FCFMYSE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

  • MYSE has a worse Return On Assets (-70.05%) than 87.77% of its industry peers.
  • Looking at the Return On Equity, with a value of -56.83%, MYSE is doing worse than 70.50% of the companies in the same industry.
Industry RankSector Rank
ROA -70.05%
ROE -56.83%
ROIC N/A
ROA(3y)-100.23%
ROA(5y)-97.03%
ROE(3y)-98.69%
ROE(5y)-103.79%
ROIC(3y)N/A
ROIC(5y)N/A
MYSE Yearly ROA, ROE, ROICMYSE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

1.3 Margins

  • MYSE does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MYSE Yearly Profit, Operating, Gross MarginsMYSE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 -200K -400K -600K -800K -1M

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. MYSE Health Analysis

2.1 Basic Checks

  • MYSE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, MYSE has more shares outstanding
  • MYSE has more shares outstanding than it did 5 years ago.
  • MYSE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MYSE Yearly Shares OutstandingMYSE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1M 2M 3M
MYSE Yearly Total Debt VS Total AssetsMYSE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

  • MYSE has an Altman-Z score of -16.31. This is a bad value and indicates that MYSE is not financially healthy and even has some risk of bankruptcy.
  • MYSE's Altman-Z score of -16.31 is on the low side compared to the rest of the industry. MYSE is outperformed by 91.73% of its industry peers.
  • MYSE has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • MYSE has a Debt to Equity ratio of 0.00. This is in the better half of the industry: MYSE outperforms 64.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -16.31
ROIC/WACCN/A
WACC10.92%
MYSE Yearly LT Debt VS Equity VS FCFMYSE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M 20M

2.3 Liquidity

  • A Current Ratio of 5.72 indicates that MYSE has no problem at all paying its short term obligations.
  • MYSE has a better Current ratio (5.72) than 89.21% of its industry peers.
  • MYSE has a Quick Ratio of 5.72. This indicates that MYSE is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 5.72, MYSE belongs to the top of the industry, outperforming 89.21% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.72
Quick Ratio 5.72
MYSE Yearly Current Assets VS Current LiabilitesMYSE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. MYSE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 35.09% over the past year.
  • MYSE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 20.00%.
EPS 1Y (TTM)35.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%32.65%
Revenue 1Y (TTM)20%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%200%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MYSE Yearly Revenue VS EstimatesMYSE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 10K 20K 30K 40K

More info and screens

Find the best growth stocksShow best growing peers

0

4. MYSE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for MYSE. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MYSE Price Earnings VS Forward Price EarningsMYSE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MYSE Per share dataMYSE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MYSE Dividend Analysis

5.1 Amount

  • MYSE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MYSE Fundamentals: All Metrics, Ratios and Statistics

MYSEUM INC

NASDAQ:MYSE (3/20/2026, 8:11:50 PM)

After market: 1.69 0 (0%)

1.69

+0.07 (+4.32%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners4.34%
Inst Owner ChangeN/A
Ins Owners4.53%
Ins Owner Change0%
Market Cap7.20M
Revenue(TTM)600
Net Income(TTM)-4.74M
AnalystsN/A
Price TargetN/A
Short Float %1.53%
Short Ratio1.04
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 11999
P/FCF N/A
P/OCF N/A
P/B 0.86
P/tB 1.01
EV/EBITDA N/A
EPS(TTM)-1.22
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.08
FCFYN/A
OCF(TTM)-1.03
OCFYN/A
SpS0
BVpS1.96
TBVpS1.67
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -70.05%
ROE -56.83%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-100.23%
ROA(5y)-97.03%
ROE(3y)-98.69%
ROE(5y)-103.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.72
Quick Ratio 5.72
Altman-Z -16.31
F-Score4
WACC10.92%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)35.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%32.65%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)20%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%200%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y1.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y29.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y34.28%
OCF growth 3YN/A
OCF growth 5YN/A

MYSEUM INC / MYSE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of MYSEUM INC (MYSE) stock?

ChartMill assigns a fundamental rating of 2 / 10 to MYSE.


What is the valuation status of MYSEUM INC (MYSE) stock?

ChartMill assigns a valuation rating of 0 / 10 to MYSEUM INC (MYSE). This can be considered as Overvalued.


Can you provide the profitability details for MYSEUM INC?

MYSEUM INC (MYSE) has a profitability rating of 0 / 10.


What is the financial health of MYSEUM INC (MYSE) stock?

The financial health rating of MYSEUM INC (MYSE) is 5 / 10.